: Drug therapy of shock. In: Shock, pathogenesis and therapy, an international symposium (CIBA). (K. D. Bocx, Ed.) Berlin-GSttingen- Heidelberg: Springer 1962.Nickerson, M. Drug therapy of shock. In: Shock. Pathogenesis and Therapy. International symposium, K. D. Bock, ed. Berlin, ...
Formulation development and evaluation, in silico PBPK modeling and in vivo pharmacodynamic studies of clozapine matrix type transdermal patches Abdul Qadir ,Syed Umer Jan &Muhammad Arsalan Article 06 January 2025|Open Access Heptamethine cyanine-based polymeric nanoparticles for photothermal therapy in HCT...
The validation of newer approaches based on microRNA targeting and gene therapy strategies, as well as the discovery of novel pathophysiological mechanisms and targets through genetic technology, may lead to the development of additional novel AF therapies. Abstract Atrial fibrillation is the most common...
WEDNESDAY, Sept. 16, 2020 (HealthDay News) -- Adding a newer drug to standard therapy might help control kidney complications caused by the autoimmune disease lupus, a new clinical trial suggests. The researchers found that adding the drug, called belimumab, improved patients' li...
Cancer was shown to be the main factor in 30-day mortality on multivariate analysis (p < 0.001), ahead of age > 65 years (p = 0.026), bacterial superinfection (p = 0.031), and initial state of shock (p = 0.042) [10]. The first data from a multicenter Chinese cohort of 1590 CO...
Beta-actin was used as a loading control C, Immunofluorescence images showing the cytoplasmic localization of HuR in different cancer cell lines. Blue – nuclear DAPI staining; Green – HuR staining. 1.2. Lung cancer (LC) Due to complex etiology and tumor heterogeneity, delayed diagnosis, and ...
It is easily understood that behavioral psychopharmacology faced with the task of dealing with extremely complex behavioral disturbances of the elderly certainly has difficulties in designing up appropriate analogue models in experimental animals for hum
However, drugs used to regulate M1/M2 macrophages have not yet been studied in large randomized clinical trials. Objective To compare the topical application of ON101 cream with use of an absorbent dressing (Hydrofiber; ConvaTec Ltd) when treating DFUs. Design, Setting, and Participants This ...
Pharmaceutical chaperones and proteostasis regulators in the therapy of lysosomal storage disorders: current perspective and future promises. Front. Pharmacol. 8, 448 (2017). Article CAS PubMed PubMed Central Google Scholar Ortolano, S., Vieitez, I., Navarro, C. & Spuch, C. Treatment of ...
However, genetic epidemiology has not yet been used to test the causality of low HDL particle number and coronary heart disease. Two short-term clinical trials of the effects of intravenous reconstituted HDLs on coronary lesions in patients with acute coronary syndrome gave encouraging results, but ...